title: Full likelihood analysis of genetic risk with variable age at onset disease--combining population-based registry data and demographic information.
abstract: BACKGROUND
  In genetic studies of rare complex diseases it is common to ascertain familial data from population based registries through all incident cases diagnosed during a pre-defined enrollment period. Such an ascertainment procedure is typically taken into account in the statistical analysis of the familial data by constructing either a retrospective or prospective likelihood expression, which conditions on the ascertainment event. Both of these approaches lead to a substantial loss of valuable data.
  
  
  RESULTS
  Here we consider instead the possibilities provided by a Bayesian approach to risk analysis, which also incorporates the ascertainment procedure and reference information concerning the genetic composition of the target population to the considered statistical model. Furthermore, the proposed Bayesian hierarchical survival model does not require the considered genotype or haplotype effects be expressed as functions of corresponding allelic effects. Our modeling strategy is illustrated by a risk analysis of type 1 diabetes mellitus (T1D) in the Finnish population-based on the HLA-A, HLA-B and DRB1 human leucocyte antigen (HLA) information available for both ascertained sibships and a large number of unrelated individuals from the Finnish bone marrow donor registry. The heterozygous genotype DR3/DR4 at the DRB1 locus was associated with the lowest predictive probability of T1D free survival to the age of 15, the estimate being 0.936 (0.926; 0.945 95% credible interval) compared to the average population T1D free survival probability of 0.995.
  
  
  CONCLUSIONS
  The proposed statistical method can be modified to other population-based family data ascertained from a disease registry provided that the ascertainment process is well documented, and that external information concerning the sizes of birth cohorts and a suitable reference sample are available. We confirm the earlier findings from the same data concerning the HLA-DR3/4 related risks for T1D, and also provide here estimated predictive probabilities of disease free survival as a function of age.
authors.affiliation: Department of Public Health, University of Helsinki, Helsinki, Finland. janne.pitkaniemi@helsinki.fi
authors.forename: Janne
authors.initials: J
authors.lastname: Pitkäniemi
authors.forename: Sirkka-Liisa
authors.initials: SL
authors.lastname: Varvio
authors.forename: Jukka
authors.initials: J
authors.lastname: Corander
authors.forename: Nella
authors.initials: N
authors.lastname: Lehti
authors.forename: Jukka
authors.initials: J
authors.lastname: Partanen
authors.forename: Eva
authors.initials: E
authors.lastname: Tuomilehto-Wolf
authors.forename: Jaakko
authors.initials: J
authors.lastname: Tuomilehto
authors.forename: Andrew
authors.initials: A
authors.lastname: Thomas
authors.forename: Elja
authors.initials: E
authors.lastname: Arjas
mesh_terms: D017668:Age of Onset; D001499:Bayes Theorem; D003710:Demography; D005387:Finland / Q000453:epidemiology; D020022:Genetic Predisposition to Disease; D006801:Humans; D016013:Likelihood Functions; D012042:Registries